BSX   $89.97  -1.67% Market Closed After Close 90.0 0.03%

Boston Scientific Corp
Total Cash 2.50B
totalCashPerShare 1.698
EBITDA 4.06B
Total Debt 11.26B
quickRatio 0.847
currentRatio 1.482
Total Revenue 15.91B
debtToEquity 53.722
Revenue/Share 10.829
ROA 0.04903
ROE 0.08916
grossProfits
freeCashflow 1.80B
operatingCashflow 2.94B
earningsGrowth -0.07
revenueGrowth 0.193
grossMargins 0.68745005
ebitdaMargins 0.25536
operatingMargins 0.17059
profitMargins 0.112629995
enterpriseValue 135.08B
forwardPE 30.659498
floatShares 1.47B
sharesOutstanding 1.47B
sharesShort 11.31M
sharesShortPriorMonth 12.20M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.93%
Short Ratio help_outline 2.06%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 14.054
Price To Book help_outline 6.09
earningsQuarterlyGrowth -0.07
netIncomeToCommon 1.79B
trailingEps 1.21%
forwardEps 2.79%
enterpriseToEbitda 33.24
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.65 4Q 2024
institutionsCount 1926
lastUpdated Nov. 6, 2024, 4:28 p.m.